---
category: news
title: "Antengene and MindRank AI Enter into Collaboration to Advance the Development of Difficult-to-Drug Molecular Targets"
excerpt: "This collaboration marks the establishment of a synergistic alliance between a leading research-driven biopharmaceutical company and an innovative AI-powered drug discovery company to transform drug discovery and development."
publishedDateTime: 2021-08-09T00:38:00Z
originalUrl: "https://markets.businessinsider.com/news/stocks/antengene-and-mindrank-ai-enter-into-collaboration-to-advance-the-development-of-difficult-to-drug-molecular-targets-1030704492"
webUrl: "https://markets.businessinsider.com/news/stocks/antengene-and-mindrank-ai-enter-into-collaboration-to-advance-the-development-of-difficult-to-drug-molecular-targets-1030704492"
type: article
quality: 44
heat: 44
published: false

provider:
  name: Business Insider
  domain: businessinsider.com
  images:
    - url: "https://everyday-cc.github.io/ai/assets/images/organizations/businessinsider.com-50x50.jpg"
      width: 50
      height: 50

topics:
  - AI

images:
  - url: "https://mma.prnewswire.com/media/1578775/English_Logo.jpg"
    width: 400
    height: 253
    isCached: true

secured: "HUBD1icnl88klyW1IGi2vZSXMLm3prgOHkP/Zk5fXWQge1ckAnkIIfonygjVZBrRgSHNII3q0Lc1aYAsyLlUhsixc+B+Tf3baPxHd1bVpmLXhvXUJYdGItIaeSInpyF8Lg9mOGfstPjPT/JUMEijYQ8mfCJ5OP3IK/9uQPUrS3RuLYivuBjuvQ2XNyXcXT7ynsep3Km3TBVVvBeUEK9G/wOOgo8A0UtzVY79PZ9vXo6AY3ZplhDXVcqk6CeiZdPkzxTf/HCted55/tJzUsmGCAymxU1rw8mNbTDFGcOWf8McF2wqXfgdje7E/r0kgHHWJuSZtXQ5U5vcTGhCd59E0TUkIWAiGEIUCsqxh6wYYpQ=;mYEnbzCZfeqynBr2Dt/NeA=="
---

